A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer-Reference-Cited by-同舟云学术

A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer

Published:2022 Issue:4 Volume:10 Page:506-517
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Alifu Nuernisha¹^ORCID,Ma Rong²,Zhu Lijun¹,Du Zhong²,Chen Shuang²,Yan Ting¹,Alimu Gulinigaer¹,Zhang Linxue¹,Zhang Xueliang¹

Affiliation:

1. State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia School of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830011, China

2. State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, Department of Gynecology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

Abstract

A novel IR-783-DOX-TMTP1 theranostic nanoplatform with strong targeting ability was prepared and used for in vivo NIR-II fluorescence imaging of intratumoral vessels and chemotherapy of cervical tumor-bearing mice.

Funder

National Natural Science Foundation of China

Department of Education, Xinjiang Uygur Autonomous Region

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D1TB02481G

Reference44 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

2. Current imaging strategies for the evaluation of uterine cervical cancer